Skip to content
Home/Companies/HealthTech/Caristo Diagnostics
Caristo Diagnostics

Caristo Diagnostics

HealthTech·UK·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Caristo Diagnostics?

Caristo Diagnostics is currently owned by Oxford Science Enterprises through Oxford Science Enterprises Balance Sheet (2015 vintage), since 2018.

Hand-verified · updated 2026-07-16

Oxford Science Enterprises
Investor
Oxford Science Enterprises
Oxford Science Enterprises Balance Sheet · 2015 · Balance Sheet

Key facts

HQUK
SectorHealthTech
StatusActive
Websitewww.caristo.com

More from Oxford Science Enterprises Balance Sheet

Other portfolio companies in the same fund.

Allos
Allos
Active
AI/MLUK· 2026
Caudal Energy
Active
EnergyUK· 2026
Densix
Active
Deep TechUK· 2026
Marley Health
Marley Health
Active
HealthTechUK· 2026
Stateful Robotics
Stateful Robotics
Active
Deep TechUK· 2026
Alethio Therapeutics
Active
BiotechUK· 2025

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Paladin
Paladin
Active
Ring CapitalFrance
Access Infinity
Active
CBPE CapitalUK· 2026
Auryx
Active
VentoUnited Kingdom· 2026
Axomove
Axomove
Active
INCO VENTURESFrance· 2026
Track Caristo Diagnostics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Caristo Diagnostics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue